Events

ESA Industry Space Days (ISD) 2026
SEP
Wed
16
SEP
Thu
17
SEP
Fri
18

Starts in 2 months from now

Location

Noordwijk (NL)

ESA ESTEC, Keplerlaan 1, 2201 AZ Noordwijk, Netherlands
Programmes
Digital, Industry & Space

ESA Industry Space Days 2026 is a biennial event that aims to bring together around 2,500 participants for networking and business exchange across the European space ecosystem. The programme is designed to help attendees engage directly with ESA and industry representatives, build relationships with clients and partners, and discuss industrial cooperation and future developments.

The event also includes exhibition opportunities, with more than 200 booths available in the exhibition hall for organisations wishing to show products, services, and capabilities relevant to ESA missions and related industrial activities. According to the source text, the event is open to entities and investors from ESA Member States, Associate States, and Cooperating States.

Registration is now open via this Registration Link.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.